Recombinant Human PRG4 Protein，His

PRG4 (Proteoglycan 4), also known as lubricin, is a glycoprotein predominantly expressed in synovial fluid and on the surfaces of articular cartilage, playing a critical role in joint lubrication and the maintenance of cartilage integrity. Research into PRG4 has gained significant attention due to its potential implications in osteoarthritis and other joint diseases, where its protective and lubricating functions may be compromised. The development of recombinant PRG4 proteins has emerged as a promising therapeutic strategy to restore lubrication in joints, offering a means to alleviate pain and improve mobility in affected individuals. Moreover, understanding the molecular mechanisms underlying PRG4 expression and function can provide insights into cartilage biology and the pathophysiology of degenerative joint diseases. Recent studies have also explored the biophysical properties of PRG4, highlighting its ability to reduce friction and wear in joint environments, thereby suggesting its utility in tissue engineering and regenerative medicine. This growing body of research positions PRG4 not only as a critical molecule in joint health but also as a potential biomarker for assessing cartilage degeneration and as a target for innovative therapeutic approaches aimed at joint preservation and repair. With ongoing advancements in recombinant protein technology, the harnessing of PRG4 could lead to significant breakthroughs in both clinical applications and fundamental research in joint biology.